EUVIMEDEUVIMED entdecken
Crossref

Serum changes in fibroblast growth factor-23 and in parameters of phosphorus metabolism after renal transplantation

EffatA.E. Tony, MohamadA Sobh, Madleen AdelA Abdou, MohamadF Ali

Journal of The Egyptian Society of Nephrology and Transplantation · 2018 · 18 (2) · 46

DOI: 10.4103/jesnt.jesnt_5_18 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of The Egyptian Society of Nephrology and Transplantation, 2018. Verfasst von EffatA.E. Tony und 3 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 46 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Kidney transplantation is the preferred treatment for chronic kidney disease, but its effect on disordered mineral metabolism is incompletely understood. Post-transplant mineral bone disease (MBD) is an important complication, although its etiology and course vary. Fibroblast growth factor (FGF23) controls phosphate and vitamin D metabolism, and its assessment increases our understanding the pathogenesis of post-transplant bone disease.

Aim

To determine the regulation of serum FGF23 in relation to other biochemical parameters in our post-transplant participants with preserved renal function.Materials and methods A case–control study conducted on 48 kidney transplant recipients, with age ≥ 18 years old and an estimated glomerular filtration rate (eGFR) > 60 ml/min/1.73m2, from the different transplantation centers during their follow-up from 2015 to 2016. They classified in equal number according to their post-transplant follow-up period into: group A; early 6 months, and group B; late 6 months. In addition, 20 healthy persons were enrolled in the study as controls. Patients with graft rejection at the time of enrollment, those with infections and neoplasms or taking medications were excluded. Participants subjected to full history taking and clinical examination. Peripheral hemogram, blood glucose, lipid profile, liver function, kidney function, urine analysis, calcium, phosphorus, parathyroid hormone (PTH), 25-hydroxyvitamin D, FGF23, and 24-h urinary phosphorus were done.

Results

Significantly high levels of FGF23, PTH, and urinary phosphorous (108.6±92.7 pg/ml, 150.7±51 pg/ ml, and 1170.5±331.1 mg/day with P

Zitieren

APA

Tony, E., Sobh, M., Abdou, M. A., & Ali, M. (2018). Serum changes in fibroblast growth factor-23 and in parameters of phosphorus metabolism after renal transplantation. Journal of The Egyptian Society of Nephrology and Transplantation, 18(2), 46. https://doi.org/10.4103/jesnt.jesnt_5_18

Vancouver

Tony E, Sobh M, Abdou MA, Ali M. Serum changes in fibroblast growth factor-23 and in parameters of phosphorus metabolism after renal transplantation. Journal of The Egyptian Society of Nephrology and Transplantation. 2018;18(2):46. doi:10.4103/jesnt.jesnt_5_18

BibTeX
@article{Tony2018,
  author = {Tony, EffatA.E. and Sobh, MohamadA and Abdou, Madleen AdelA and Ali, MohamadF},
  title = {Serum changes in fibroblast growth factor-23 and in parameters of phosphorus metabolism after renal transplantation},
  journal = {Journal of The Egyptian Society of Nephrology and Transplantation},
  year = {2018},
  volume = {18},
  number = {2},
  pages = {46},
  doi = {10.4103/jesnt.jesnt_5_18}
}
Kostenlos starten →